guest ::
| Home > Publications database > FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. > print |
| Home > Publications database > FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. > print |
| 001 | 144403 | ||
| 005 | 20240229123018.0 | ||
| 024 | 7 | _ | |a 10.1038/s41418-019-0385-7 |2 doi |
| 024 | 7 | _ | |a pmid:31285543 |2 pmid |
| 024 | 7 | _ | |a 1350-9047 |2 ISSN |
| 024 | 7 | _ | |a 1476-5403 |2 ISSN |
| 024 | 7 | _ | |a altmetric:63279185 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2019-01856 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Richter, Kai |0 P:(DE-He78)f08cb94a1ca44e0f65e828ea1c2edca4 |b 0 |e First author |
| 245 | _ | _ | |a FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. |
| 260 | _ | _ | |a London |c 2020 |b Macmillan |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1634904202_21237 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Feb;27(2):758-772#EA:F045#LA:F045# |
| 520 | _ | _ | |a Cell fate decision upon prolonged mitotic arrest induced by microtubule-targeting agents depends on the activity of the tumor suppressor and F-box protein FBXW7. FBXW7 promotes mitotic cell death and prevents premature escape from mitosis through mitotic slippage. Mitotic slippage is a process that can cause chemoresistance and tumor relapse. Therefore, understanding the mechanisms that regulate the balance between mitotic cell death and mitotic slippage is an important task. Here we report that FBXW7 protein levels markedly decline during extended mitotic arrest. FBXO45 binds to a conserved acidic N-terminal motif of FBXW7 specifically under a prolonged delay in mitosis, leading to ubiquitylation and subsequent proteasomal degradation of FBXW7 by the FBXO45-MYCBP2 E3 ubiquitin ligase. Moreover, we find that FBXO45-MYCBP2 counteracts FBXW7 in that it promotes mitotic slippage and prevents cell death in mitosis. Targeting this interaction represents a promising strategy to prevent chemotherapy resistance. |
| 536 | _ | _ | |a 316 - Infections and cancer (POF3-316) |0 G:(DE-HGF)POF3-316 |c POF3-316 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Kschonsak, Yvonne T |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Vodicska, Barbara |0 P:(DE-He78)df9c47af8df9bd3d1243d61712a864f5 |b 2 |e Last author |
| 700 | 1 | _ | |a Hoffmann, Ingrid |0 P:(DE-He78)b97fa0c782a162d952b6197f3b916379 |b 3 |e Last author |
| 773 | _ | _ | |a 10.1038/s41418-019-0385-7 |0 PERI:(DE-600)1496681-5 |n 2 |p 758-772 |t Cell death and differentiation |v 27 |y 2020 |x 1476-5403 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:144403 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)f08cb94a1ca44e0f65e828ea1c2edca4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)df9c47af8df9bd3d1243d61712a864f5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)b97fa0c782a162d952b6197f3b916379 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-316 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Infections and cancer |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL DEATH DIFFER : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL DEATH DIFFER : 2017 |
| 920 | 2 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellykluskontrolle und Carcinogenese |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellzykluskontrolle und Karzinogenese |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellykluskontrolle und Carcinogenese |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)F045-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|